Executive Oncology Account Manager (Durham)

Durham, NC

Posted$210K to $220K · period not statedfirst seen Nov 3, 2026updated Nov 2, 2026

When this one is worth applying to

Assisted apply Apply on Summit Therapeutics's posting

Assisted apply drafts a resume, a cover letter and screening answers for this posting from your Source of You record, and drops figures it cannot find there. Applying always happens on the company's own page.

The posting, in Summit Therapeutics's own words

archived Nov 3, 2026

1 skills recognized in this posting, underlined below. Sign up free to see which ones your record already covers →

About Summit:

Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland. Location: Durham, NC (Field Based)

Overview of Role:

The Executive Oncology Account Manager (OAM) will be responsible for driving the successful launch and commercialization of ivonescimab within an assigned U.S. territory. Reporting to a Regional Business Director (RBD), this individual contributor role is accountable for developing and executing territory-level business plans, building strong customer relationships, and achieving sales objectives in alignment with national and regional commercial strategies. The Executive Oncology Account Manager will engage oncology customers across community practices, academic centers, integrated delivery networks, and other key accounts to support appropriate product education and access. This role will collaborate closely with cross-functional partners, including Marketing, Market Access, Medical Affairs, Commercial Operations, and regional leadership, to deliver a best-in-class customer experience and support business performance.

Read the full posting ↓

Role and Responsibilities:

Develop and execute territory business plans to achieve sales objectives, market share goals, and product launch priorities within the assigned geography. Build and maintain strong relationships with oncology healthcare professionals, key opinion leaders, practice administrators, and other relevant stakeholders. Effectively communicate product information, clinical value, and approved promotional messaging in accordance with company policies and compliance standards. Analyze territory performance, customer needs, market trends, and competitive dynamics to identify opportunities and adjust business plans accordingly. Partner with the Regional Business Director to align territory priorities with regional strategies, performance expectations, and launch execution plans. Collaborate with Marketing, Medical Affairs, Market Access, Commercial Operations, and other cross-functional partners to support customer engagement and business objectives. Provide customer insights, competitive intelligence, and market feedback to regional leadership and internal stakeholders. Plan and conduct compliant customer interactions, including in-person and virtual engagements, speaker programs, business reviews, and other approved promotional activities. Maintain accurate and timely documentation of customer interactions, territory plans, expenses, and required administrative activities. Ensure all commercial activities are conducted in compliance with company policies, industry regulations, and applicable legal requirements. Manage territory travel, expenses, and resources responsibly. All other duties as assigned.

Experience, Education and Specialized Knowledge and Skills:

Bachelor's degree in business, life sciences, or related field required; advanced degree preferred. Minimum of 6+ years of pharmaceutical or biotechnology commercial experience with at least 3+ years of oncology experience preferred, with demonstrated clinical acumen, strong commercial performance, and experience influencing treatment decisions in competitive markets; or relevant combination of commercial, education and life experience. Recent experience supporting oncology product launches preferred; NSCLC experience strongly preferred. Demonstrated success achieving or exceeding sales goals within a defined territory. Strong understanding of the oncology marketplace, treatment landscape, customer environment, and account-based selling. Proven ability to analyze sales data, market trends, and customer insights to inform territory planning and execution. Excellent communication, presentation, negotiation, and relationship-building skills. Ability to work independently while collaborating effectively with regional leadership and cross-functional partners, with demonstrated accountability, adaptability, and proactive problem solving. Strong business acumen, organizational skills, strategic territory planning, data-driven decision making, and ability to prioritize within a dynamic launch environment. Strong understanding of FDA, OIG, and industry compliance requirements governing the promotion of prescription drugs, with a track record of operating with the highest ethical standards. Proficiency with CRM platforms and data analytics tools (e.g., Veeva, Salesforce) to track activity, segment accounts, and measure performance. Proficiency with Microsoft Office and virtual meeting and presentation tools. Valid driver's license and a clean driving record; ability to travel within the assigned geography. Willingness and ability to travel as required by territory design and business needs, including overnight travel and weekend exhibits and conventions.

Preferred Experience:

Experience with immuno-oncology, targeted therapy, or novel biologic agents (e.g., PD-1/PD-L1 inhibitors, bispecific antibodies) preferred. Working knowledge of biomarker and molecular testing pathways, including EGFR and other actionable alterations in NSCLC, and how they inform treatment selection. Demonstrated ability to build and sustain relationships with key opinion leaders, thoracic oncologists, pharmacists, and multidisciplinary tumor board participants across academic and community settings. Experience navigating complex oncology accounts, including academic medical centers, health systems, and integrated delivery networks, with an understanding of formulary, reimbursement, and buy-and-bill dynamics. Knowledge of the oncology access and reimbursement landscape, including payer policies, prior authorization, specialty pharmacy, and patient support services. This is the pay for this position Pay Transparency $210,000 — $220,000 USD Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation. Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit. Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.